Description
Provider of financial services to biopharmaceutical companies. The company finances clinical stage companies that develop new biological entities or new therapeutically platforms in the treatment for various diseases, rare diseases and diseases with unmet needs.
Contact Information
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
Name | Title | Board Seat | Contact Info |
---|---|---|---|
Ulrike Dickmann | President & Chief Executive Officer | ||
Wolfgang Kochs | Director & Chief Financial Officer |